<code id='26DC6B09D4'></code><style id='26DC6B09D4'></style>
    • <acronym id='26DC6B09D4'></acronym>
      <center id='26DC6B09D4'><center id='26DC6B09D4'><tfoot id='26DC6B09D4'></tfoot></center><abbr id='26DC6B09D4'><dir id='26DC6B09D4'><tfoot id='26DC6B09D4'></tfoot><noframes id='26DC6B09D4'>

    • <optgroup id='26DC6B09D4'><strike id='26DC6B09D4'><sup id='26DC6B09D4'></sup></strike><code id='26DC6B09D4'></code></optgroup>
        1. <b id='26DC6B09D4'><label id='26DC6B09D4'><select id='26DC6B09D4'><dt id='26DC6B09D4'><span id='26DC6B09D4'></span></dt></select></label></b><u id='26DC6B09D4'></u>
          <i id='26DC6B09D4'><strike id='26DC6B09D4'><tt id='26DC6B09D4'><pre id='26DC6B09D4'></pre></tt></strike></i>

          Home / comprehensive / leisure time

          leisure time


          leisure time

          author:explore    Page View:72691
          Adam's take main illustration
          Molly Ferguson/STAT

          Biotech is awash in PIPEs.

          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

          advertisement

          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In